IQVIA Review: What the Company Does, Its Market Intelligence Arm, and What Employees Say
By Jan Suski. I go deep on every review, checking every number against its source and digging up details other coverage misses, a habit from six years of SEO and link building for tech companies. Bylines at Surfer, Brand24, and Senuto. How the scoring works.
·
Best for
Pharma and biotech companies that need trial execution and real-world evidence from a single vendor covering both clinical work and healthcare data.
Not for
Buyers who need a fast, low-friction support experience; that's the weak point reviewers name most often behind an otherwise strong scale story.
What it costs
No published rate card. IQVIA sells contracted, scoped engagements; only disclosed government deals show real numbers, like $2.17 million from the FDA.
- Clinical trials
- All phases, including decentralized trials that drop the physical site visit
- Real-world data
- Privacy-protected outcome analysis across oncology, diabetes and rare diseases
- Commercial strategy
- Pricing, market access and launch sequencing for new drugs
- Drug development
- None. It's a contract research & data partner, not a manufacturer
- CRO rivals
- ICON plc and Parexel
- Data rivals
- Evaluate and Clarivate
- Formed
- 2016, from the merger of IMS Health and Quintiles
- Headcount
- Approximately 93,000 people
- Footprint
- More than 100 countries, with a large campus in Durham, North Carolina
- Stock listing
- NYSE: IQV, large enough by revenue and headcount to sit in the Fortune 500
- Twelve-month price
- $323,318.76 for COVID-19 pharmaceutical data, June 2020 to May 2021
- Employee rating
- 3.7 out of 5; 72% would recommend it to a friend
- Open roles
- Over 4,969 listed at any given time
- Remote work
- 4.4 stars for telecommuting, flat since March 2020; employees set their own schedules
- Paid time off
- Sick, vacation and personal days kept separate, rated 3.8; no unlimited policy
- Learning opportunities
- 2.7 out of 5; 41% say growth is a manager priority, 52% get the feedback they need
- Management opportunities
- 3.6 stars
- Women in leadership
- 3.8 stars with a mentorship program; 67% felt paid fairly at hire
- Recurring criticisms
- Workflow complexity, inconsistent customer support, operational bureaucracy
- Rate card
- None. IQVIA sells contracted research and data services, not a listed product
- What you buy
- Engagements scoped per programme, from trial design through post-approval commercial strategy
- Scale behind the quote
- Roughly 93,000 staff in more than 100 countries, listed on the NYSE as IQV
- UK public contract
- £38,768 excluding VAT, one year of the antimicrobial dispensing dataset for the UK Health Security Agency, to 31 October 2026
- FDA contract
- $2,171,621.71 for global pharmaceutical sales data, August 2019 to September 2022, roughly $723,900 a year
Not forA sponsor needing a trial run; Evaluate sells the forecast, while IQVIA delivers the study.
Not forA commercial team after Rx data; Cortellis tracks filings and pipelines, while IQVIA holds the prescription data itself.
Pairs well with IQVIA
Which figures describe the company, and which are employee-submitted ratings
Headcount, country count and the NYSE listing describe the company as IQVIA reports itself. Every star rating and percentage here, from the 3.7 overall down to the 2.7 on learning opportunities, comes from employee-submitted reviews, so read them as sentiment over a sample size nobody publishes.
IQVIA prints no rate card, so the three prices on the cost side are published public contracts: what the UK Health Security Agency, the FDA and the CDC each paid for a named dataset, with the buyer, the scope and the term attached to each. None of them is a list price.
This IQVIA review covers two separate questions people search for under the same name: what IQVIA does as a healthcare data & clinical research company, and what it's like to work there. Both matter to different readers, so both get answered with numbers.
↑ FACT SHEETWhat Does IQVIA Do?
IQVIA is a global provider of advanced analytics and clinical research services, formed in 2016 when IMS Health merged with Quintiles. The company employs approximately 93,000 people across more than 100 countries, running clinical trials, building healthcare data platforms, and selling market intelligence and health economics research to pharma & biotech clients.
Is IQVIA a Pharma Company?
No. IQVIA doesn't develop or sell drugs itself. It supports the entire lifecycle of a drug or medical device, from clinical trial design through commercial strategy after approval, working as a contract research & data partner to pharma companies.
Clinical Development Services
IQVIA runs clinical trials across all phases, & is known for managing decentralized, technology-enabled trials that don't require every patient visit to happen at a physical site. That model matters for patient outcomes: a decentralized trial can recruit patients who'd otherwise be excluded by distance from a study site.
Real-World Data & Healthcare Analytics
IQVIA uses privacy-protected data to analyze real-world patient outcomes at a scale few competitors can match, & is widely recognized as a leader in healthcare data analytics. The company's portfolio spans oncology, diabetes, and rare diseases, where real-world evidence is often the difference between a drug getting reimbursed and a payer refusing to cover it.
IQVIA's Market Intelligence & Commercial Strategy Work
IQVIA's platform integrates data resources with analytics & healthcare expertise to support commercial strategy decisions: pricing, market access, and launch sequencing for new drugs. That's the market intelligence side of the business, distinct from the clinical trial side, and it's why IQVIA shows up on pharma shortlists next to specialist tools like Evaluate for consensus forecasting.
↑ FACT SHEETIs IQVIA a Fortune 500 Company?
Yes. IQVIA (NYSE: IQV) is large enough by revenue & headcount to sit among the Fortune 500, consistent with a company employing roughly 93,000 people worldwide across clinical research, technology, and data analytics.
Who Is IQVIA's Biggest Competitor?
Depends on which business line. In contract clinical research, IQVIA competes with ICON plc and Parexel. In healthcare data & market intelligence, it competes with smaller specialists like Evaluate and Clarivate, though none match IQVIA's combined scale across clinical trials and analytics in a single company.
↑ FACT SHEETIQVIA Pricing
IQVIA publishes no rate card, so the only hard numbers come from public buyers who had to disclose what they paid. Three published contracts cover named datasets. None of them is a list price.
The UK Health Security Agency paid £38,768 excluding VAT, £46,521.60 including it, for one year of the Private Sector Dispensing of Antimicrobials dataset, a series the tender notice describes as "collected exclusively by IQVIA Ltd". The award runs 1 November 2025 to 31 October 2026 under reference C395320, granted without competition because it sat below the tender threshold.
Federal buyers paid more for wider data. The FDA committed $2,171,621.71 on purchase order 75F40119P10550 to "obtain access to data resource(s) to enable FDA capture global, national-level pharmaceutical sales data, by country", a firm fixed price award made sole source under FAR 6.302-1 with one offer received, running 28 August 2019 to 3 September 2022. Across that three-year term it averages roughly $723,900 a year.
The cleanest single-year figure is the CDC's. It paid $323,318.76 for "Pharmaceutical data for COVID-19" over exactly twelve months, 1 June 2020 to 31 May 2021, firm fixed price with no competition.
Those three are what public health agencies paid for named IQVIA datasets, nothing more. Commercial pharma buys a different and larger thing: trial delivery, real-world evidence programmes and launch strategy scoped per drug, and IQVIA prints no figure for any of it.
↑ FACT SHEETIQVIA Employee Ratings
IQVIA has an employee rating of 3.7 out of 5 stars, and 72% of employees would recommend IQVIA to a friend. The following categories break that overall score down by topic, based on employee-submitted ratings.
Management Opportunities
Management opportunities at IQVIA rate 3.6 stars, with over 4,969 open jobs listed at any given time, including team and talent management roles.
Remote Work Flexibility
IQVIA scores 4.4 stars for telecommuting flexibility, a rating that's averaged 4.4 stars since March 2020. Employees can set their own work schedules.
Paid Time Off
IQVIA employees rate paid time off 3.8 stars. Sick days, vacation days, and personal days are offered separately, and 72% of employees would recommend IQVIA for its benefits specifically.
Learning Opportunities
Learning opportunities score lower than other categories at 2.7 out of 5. IQVIA offers on- and off-site skills training plus speaker series and conferences, but only 41% of employees feel growth is a priority for their managers, and 52% feel they get the feedback they need to succeed.
Women in Leadership
IQVIA scores 3.8 stars for women in leadership, with a mentorship program aimed at women & stated equal opportunity for promotions. 67% of employees feel they were paid fairly when hired.
IQVIA Culture & Careers
IQVIA's careers site lists openings across clinical development, data science, and commercial teams, with a large campus in Durham, North Carolina alongside offices worldwide, serving life sciences clients from trial design through launch. Culture feedback on the careers page & third-party review sites (aggregated the way Google surfaces star ratings for any business) points to steady pay & benefits against inconsistent management, echoing the category ratings above.
Job security reads as reasonably stable given the open-role volume: with thousands of positions open across clinical development and data teams supporting patients & drug programs worldwide, IQVIA isn't a company shrinking its workforce, even where individual manager quality varies.
Is It Hard to Get Hired at IQVIA?
With over 4,969 open jobs at a given time across a 93,000-person global company, IQVIA hires at volume. That doesn't mean every role is easy to land, but the job count itself signals broad, ongoing hiring.
Does IQVIA Allow Work From Home?
Yes. IQVIA's 4.4-star telecommuting rating and flexible scheduling indicate consistent remote-work support, & that rating has held steady since March 2020.
Is IQVIA an Ethical Company?
Mixed, based on employee feedback. IQVIA is viewed favorably for healthcare data quality and analytical capability, but employees also describe workflow complexity, inconsistent customer support, and operational bureaucracy as recurring criticisms. Neither the praise nor the criticism is about ethics violations specifically; both are about execution & management consistency at a company operating in over 100 countries.
Does IQVIA Have Unlimited PTO?
No. IQVIA offers structured sick days, vacation days, and personal days, rated 3.8 stars by employees.
Is IQVIA a Reputable Company?
By the numbers, yes with caveats. A 3.7-star overall employee rating and 72% recommend-to-a-friend rate put IQVIA in solid territory, short of exceptional. Its reputation splits cleanly along the same line as the rest of this review: strong on global clinical trial expertise and healthcare data capability, weaker on management consistency and day-to-day workflow.
IQVIA FAQ
What does IQVIA do?
IQVIA runs clinical trials, builds healthcare data & analytics platforms, and sells market intelligence and commercial strategy services to pharma and biotech companies. It's a data & services company. No drugs are manufactured.
Is IQVIA a pharma company?
No. IQVIA supports pharma companies through clinical research, real-world data, and market intelligence, but it doesn't develop or sell its own drugs.
Is IQVIA a Fortune 500 company?
Yes, consistent with its scale: roughly 93,000 employees across more than 100 countries and a publicly traded stock on the NYSE under ticker IQV.
Who is IQVIA's biggest competitor?
ICON plc and Parexel in contract clinical research; Evaluate and Clarivate in healthcare data and market intelligence. No single competitor matches IQVIA's combined scale across both.
Is IQVIA a reputable company?
Employee ratings put it at 3.7 out of 5 stars with a 72% recommend rate, reflecting real strengths in clinical trial and data capability alongside real criticism of management consistency.
Does IQVIA allow work from home?
Yes, with a 4.4-star telecommuting rating that's held steady since March 2020, plus employee-set work schedules.
Does IQVIA have unlimited PTO?
No. Time off is structured into sick days, vacation days, and personal days, rated 3.8 stars overall.
Bottom Line
IQVIA is a data & clinical research company with no pharma arm, & the two sides of this review reflect two different audiences. As a market intelligence and healthcare data vendor, it's a scale leader with real-world evidence capability few competitors can match. As an employer, ratings around 3.7 stars & a 72% recommend rate describe a large, flexible, occasionally bureaucratic company, closer to solid than exceptional on either count.